We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Register to vote Register by 18 June to vote in the General Election on 4 July.
Use this form to notify the IPO of marketing authorisation for a medicinal or plant protection product, granted after your application for an SPC for that product.
Details of the process changes for established medicines, effective from 1 March 2024, which apply specifically to chemical products.
The approach the MHRA intends to take for products approved or pending in decentralised procedure (DCP) or mutual recognition procedures (MRP).
This guidance covers ‘grandfathering’ and managing the lifecycle changes of medicinal products.
How marketing authorisation holders should provide educational materials to MHRA for assessment and approval prior to launching their products on the UK market.
The MHRA will review applications for orphan designation at the time of a marketing authorisation (MA) or variation application.
Information for manufacturers of medical devices about reporting adverse incidents and field safety corrective actions to the MHRA.
The seeds which must be certified before you can market them, how to get them certified and how to get a licence for your seed business.
How to change the ownership from one marketing authorisation (MA) holder to another.
Marketing authorisations granted in 2024
An overview of the process including submitting or fast-tracking an application, naming your medicine and paying fees.
The Veterinary Medicines Directorate may suspend or expire a licence to market an animal medicine if it fails to comply with the regulations.
How to register your medical devices with the Medicines and Healthcare products Regulatory Agency (MHRA) for the markets in Great Britain and Northern Ireland
This is the Hub for all the Veterinary Medicines Directorate's communications on current and future regulatory changes.
A wholesale dealer in Great Britain may import Qualified Person certified medicines from the European Economic Area if certain checks are made by the ‘Responsible Person (import)’
Marking, labelling and marketing standards you must follow to import and export plant seeds, food and manufactured goods.
Marketing authorisations (MAs) granted since January 2014.
A new pathway supporting innovative approaches to the safe, timely and efficient development of medicines to improve patient access.
How to apply for a clinical trial including eligibility, phases, model IMPDs, costs and how to make changes to your application.
Marketing Authorisation Holders should review their manufacturing processes to identify and, if found, to mitigate the risk of nitrosamine impurities being present.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).